The company aims to become a strong entrant in the weight-loss market before 2030 and eventually a top-three competitor in ...

Swiss drugmaker Roche signalled its ambition to join Eli Lilly and Novo Nordisk at the top of the booming weight-loss market ...

Roche has reported a phase 3 win for its oral selective estrogen receptor degrader (SERD), bouncing back from an earlier ...

Roche Holding AG will move an experimental obesity shot into late-stage trials next year in a bid to challenge leaders in the ...

Roche Holding AG’s experimental drug giredestrant helped patients with a form of advanced breast cancer live longer without ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

The global In Vitro Diagnostics Quality Control Market, valued at US$1.58 billion in 2024, stood at US$1.65 billion in 2025 and is projected ...

It’s been less than two years since Roche dove into the obesity space with its $2.7 billion acquisition of Carmot ...

Roche acquires 89bio for up to $3.5B, betting on pegozafermin for MASH. Click here to read the latest analysis on ETNB and ...

According to Precedence Research, the global liquid biopsy market size will grow from USD 7.05 billion in 2025 to nearly USD ...